Vivos Inc. (RDGL)
USD 0.12
(-2.79%)
USD 0.12
(-2.79%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.78 Million USD | -0.79% |
| 2022 | 2.52 Million USD | 0.83% |
| 2021 | 2.5 Million USD | 271.66% |
| 2020 | 673.91 Thousand USD | -49.46% |
| 2019 | 1.33 Million USD | -46.06% |
| 2018 | 2.47 Million USD | -5.68% |
| 2017 | 2.62 Million USD | -41.03% |
| 2016 | 4.44 Million USD | 70.86% |
| 2015 | 2.6 Million USD | 31.51% |
| 2014 | 1.97 Million USD | -45.28% |
| 2013 | 3.61 Million USD | -40.21% |
| 2012 | 6.04 Million USD | 109.1% |
| 2011 | 2.89 Million USD | -25.21% |
| 2010 | 3.86 Million USD | 40.87% |
| 2009 | 2.74 Million USD | -54.65% |
| 2008 | 6.05 Million USD | 127.13% |
| 2007 | 2.66 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 484.5 Thousand USD | -44.06% |
| 2024 Q2 | 434.4 Thousand USD | 8.36% |
| 2023 Q2 | 911.9 Thousand USD | 269.52% |
| 2023 FY | 2.5 Million USD | -0.79% |
| 2023 Q3 | 694.63 Thousand USD | -23.83% |
| 2023 Q4 | 866.15 Thousand USD | 24.69% |
| 2023 Q1 | 246.78 Thousand USD | -64.82% |
| 2022 Q1 | 757.49 Thousand USD | 266.93% |
| 2022 FY | 2.52 Million USD | 0.83% |
| 2022 Q4 | 701.42 Thousand USD | 159.28% |
| 2022 Q3 | 270.53 Thousand USD | -66.01% |
| 2022 Q2 | 796.02 Thousand USD | 5.09% |
| 2021 FY | 2.5 Million USD | 271.66% |
| 2021 Q1 | 235.09 Thousand USD | -18.84% |
| 2021 Q2 | 1.85 Million USD | 688.5% |
| 2021 Q3 | 209.47 Thousand USD | -88.7% |
| 2021 Q4 | 206.44 Thousand USD | -1.45% |
| 2020 Q2 | 128.45 Thousand USD | 6.71% |
| 2020 Q4 | 289.64 Thousand USD | 113.86% |
| 2020 Q1 | 120.37 Thousand USD | -62.39% |
| 2020 FY | 673.91 Thousand USD | -49.46% |
| 2020 Q3 | 135.44 Thousand USD | 5.44% |
| 2019 FY | 1.33 Million USD | -46.06% |
| 2019 Q3 | 615.2 Thousand USD | 255.58% |
| 2019 Q4 | 320.02 Thousand USD | -47.98% |
| 2019 Q1 | 225.2 Thousand USD | -86.94% |
| 2019 Q2 | 173.01 Thousand USD | -23.17% |
| 2018 Q2 | 341.9 Thousand USD | 27.05% |
| 2018 Q3 | 136.9 Thousand USD | -59.96% |
| 2018 FY | 2.47 Million USD | -5.68% |
| 2018 Q4 | 1.72 Million USD | 1159.36% |
| 2018 Q1 | 269.11 Thousand USD | -59.91% |
| 2017 Q3 | 961.79 Thousand USD | 55.34% |
| 2017 FY | 2.62 Million USD | -41.03% |
| 2017 Q4 | 671.22 Thousand USD | -30.21% |
| 2017 Q2 | 619.17 Thousand USD | 67.9% |
| 2017 Q1 | 368.76 Thousand USD | 380.8% |
| 2016 Q2 | 3.22 Million USD | 369.41% |
| 2016 FY | 4.44 Million USD | 70.86% |
| 2016 Q4 | -131.32 Thousand USD | -119.71% |
| 2016 Q3 | 666.41 Thousand USD | -79.32% |
| 2016 Q1 | 686.58 Thousand USD | -57.72% |
| 2015 Q3 | 305.86 Thousand USD | -7.59% |
| 2015 FY | 2.6 Million USD | 31.51% |
| 2015 Q2 | 330.97 Thousand USD | -2.79% |
| 2015 Q1 | 340.47 Thousand USD | -11.25% |
| 2015 Q4 | 1.62 Million USD | 430.93% |
| 2014 Q1 | 559.49 Thousand USD | 36.08% |
| 2014 FY | 1.97 Million USD | -45.28% |
| 2014 Q2 | 541.83 Thousand USD | -3.16% |
| 2014 Q4 | 383.63 Thousand USD | -22.19% |
| 2014 Q3 | 493.05 Thousand USD | -9.0% |
| 2013 Q2 | 1.18 Million USD | -21.93% |
| 2013 FY | 3.61 Million USD | -40.21% |
| 2013 Q1 | 1.51 Million USD | -3.91% |
| 2013 Q4 | 411.16 Thousand USD | -18.57% |
| 2013 Q3 | 504.9 Thousand USD | -57.33% |
| 2012 Q1 | 1.08 Million USD | 38.52% |
| 2012 FY | 6.04 Million USD | 109.1% |
| 2012 Q4 | 1.57 Million USD | -32.09% |
| 2012 Q3 | 2.32 Million USD | 119.49% |
| 2012 Q2 | 1.05 Million USD | -2.75% |
| 2011 Q1 | 842.8 Thousand USD | -28.5% |
| 2011 Q2 | 700.1 Thousand USD | -16.93% |
| 2011 Q3 | 563.02 Thousand USD | -19.58% |
| 2011 Q4 | 785.49 Thousand USD | 39.51% |
| 2011 FY | 2.89 Million USD | -25.21% |
| 2010 Q1 | 1.09 Million USD | 67.45% |
| 2010 FY | 3.86 Million USD | 40.87% |
| 2010 Q3 | 1.04 Million USD | 88.36% |
| 2010 Q4 | 1.17 Million USD | 12.99% |
| 2010 Q2 | 553.8 Thousand USD | -49.2% |
| 2009 FY | 2.74 Million USD | -54.65% |
| 2009 Q4 | 651.06 Thousand USD | -23.59% |
| 2009 Q3 | 852.03 Thousand USD | 35.15% |
| 2009 Q2 | 630.41 Thousand USD | 3.21% |
| 2009 Q1 | 610.82 Thousand USD | -73.83% |
| 2008 Q1 | 1.46 Million USD | 0.0% |
| 2008 Q4 | 2.33 Million USD | 118.29% |
| 2008 Q2 | 1.67 Million USD | 14.14% |
| 2008 Q3 | 1.06 Million USD | -36.14% |
| 2008 FY | 6.05 Million USD | 127.13% |
| 2007 FY | 2.66 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 740.67 Thousand USD | -276.293% |
| IR-Med Inc. | 4.89 Million USD | 43.05% |
| Polarean Imaging plc | 12.24 Million USD | 77.234% |
| Medical Supply International USA, Inc. | 1.32 Million USD | -111.065% |
| Avitar, Inc. | 3.56 Million USD | 21.919% |
| AVITA Medical, Inc. | 80.77 Million USD | 96.55% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | -296.459% |
| Össur hf. | 396.18 Million USD | 99.297% |
| Zecotek Photonics Inc. | 3.46 Million USD | 19.481% |
| QHSLab, Inc. | 961.65 Thousand USD | -189.825% |
| Wellstar International, Inc. | 1.79 Million USD | -55.297% |
| Össur hf. | 396.18 Million USD | 99.297% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 87.202% |
| Escalon Medical Corp. | 5.25 Million USD | 46.919% |
| Aurora Spine Corporation | 8.65 Million USD | 67.807% |
| BrainsWay Ltd. | 28.01 Million USD | 90.052% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 9.56 Million USD | 70.859% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 91.698% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 99.734% |
| Kelyniam Global, Inc. | 2.27 Million USD | -22.497% |
| REMSleep Holdings, Inc. | 1.01 Million USD | -174.618% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -539.979% |
| Nanomix Corporation | 8.36 Million USD | 66.692% |
| Theraclion SA | 7.43 Million USD | 62.538% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 1.29 Million USD | -115.291% |
| Positron Corporation | 1 Million USD | -176.695% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | 10.395% |
| Lombard Medical, Inc. | 30.29 Million USD | 90.799% |
| ALR Technologies Inc. | 6.33 Million USD | 56.011% |
| Stratec SE | 46.32 Million USD | 93.983% |
| Vycor Medical, Inc. | 1.27 Million USD | -118.518% |
| Heart Tronics, Inc. | 14.46 Million USD | 80.725% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -2212.455% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -1250.22% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 80.305% |
| VMS Rehab Systems, Inc. | 63.63 USD | -4380082.304% |
| Guided Therapeutics, Inc. | 3.49 Million USD | 20.209% |
| Ingen Technologies, Inc. | 1.88 Million USD | -48.076% |
| Odyssey Group International, Inc. | -14.26 Million USD | 119.543% |
| United American Healthcare Corporation | 59 Thousand USD | -4623.915% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -583.979% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | -339.131% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | -64.376% |
| Urologix, Inc. | 10.09 Million USD | 72.383% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | -120.616% |
| Nexeon MedSystems Inc. | 5.94 Million USD | 53.144% |
| SS Innovations International, Inc. | 21.38 Million USD | 86.965% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -1110.519% |
| Smith & Nephew plc | 3.46 Billion USD | 99.92% |
| NIOX Group Plc | 22.27 Million USD | 87.489% |
| Fuse Medical, Inc. | 10.35 Million USD | 73.071% |
| Broncus Holding Corporation | 38.15 Million USD | 92.695% |
| Brain Scientific Inc. | 9.66 Million USD | 71.156% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 72.948% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -4491.766% |